Immunofluorescence analysis revealed that tumor cell proliferation was significantly downregulated in the IEVs-PFD/138-treated group as evidenced by the decreased immunofluorescence intensity of the proliferation marker Ki67 (Fig. 6g). Here, MKI67 is linked to neoplasm.